The researchers also found that repolarization of LAMs through targeting of the SAPK/JNK pathway and IRF7-SAPK/JNK pathway by interferon regulatory factor 7 (IRF7) can prolong the survival of AML mice, providing regarded a new immunotherapy strategy against leukemia (96, 98). Here, MAPK9 is linked to acute myeloid leukemia.